|
Adenocarcinoma
|
0.010 |
GeneticVariation
|
group |
BEFREE |
ING1 and p53 tumor suppressor gene alterations in adenocarcinomas of the esophagogastric junction.
|
12637159 |
2003 |
|
Ameloblastoma
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
We analyzed the loss of heterozygosity (LOH) status of the ING family (ING1-ING5) chromosomal loci in a group of ameloblastomas by microsatellite analysis, and correlated the ING LOH status with clinicopathological characteristics.
|
20681410 |
2010 |
|
Coronary heart disease
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Apolipoprotein E (APOE) E4, apolipoprotein B-100 (APOB) Q3611 allele, the angiotensin converting enzyme (ACE) deletion (D) allele and glycoprotein IIIa (GP3A) P33 mutant allele are reported to predispose to early-onset coronary heart disease (CHD).
|
10463820 |
1999 |
|
Neck Neoplasms
|
0.010 |
GeneticVariation
|
group |
BEFREE |
Molecular analysis of the candidate tumor suppressor gene ING1 in human head and neck tumors with 13q deletions.
|
10679922 |
2000 |
|
Secondary Neoplasm
|
0.010 |
GeneticVariation
|
group |
BEFREE |
Our study demonstrates that overexpression of let-7b in gastric cancer can inhibit invasion and migration of gastric cancer cells through directly targeting the tumor metastasis-associated gene ING1.
|
25613480 |
2015 |
|
trachomatis
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
The p47 GTPases Igtp and Irgb10 map to the Chlamydia trachomatis susceptibility locus Ctrq-3 and mediate cellular resistance in mice.
|
16959883 |
2006 |
|
Squamous cell carcinoma of the head and neck
|
0.710 |
Biomarker
|
disease |
BEFREE |
Because ING1 resides on the long arm of chromosome 13 (13q34) (a region frequently deleted in many tumor types), we sought to characterize its role in head and neck squamous-cell carcinoma (HNSCC).
|
10679922 |
2000 |
|
Squamous cell carcinoma of the head and neck
|
0.710 |
Biomarker
|
disease |
CTD_human |
|
|
|
|
Malignant neoplasm of stomach
|
0.320 |
Biomarker
|
disease |
CTD_human |
A gene expression signature of acquired chemoresistance to cisplatin and fluorouracil combination chemotherapy in gastric cancer patients.
|
21364753 |
2011 |
|
Contact Dermatitis
|
0.300 |
Biomarker
|
disease |
CTD_human |
Genes specifically modulated in sensitized skins allow the detection of sensitizers in a reconstructed human skin model. Development of the SENS-IS assay.
|
25724174 |
2015 |
|
Stomach Neoplasms
|
0.300 |
Biomarker
|
group |
CTD_human |
A gene expression signature of acquired chemoresistance to cisplatin and fluorouracil combination chemotherapy in gastric cancer patients.
|
21364753 |
2011 |
|
Contact hypersensitivity
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Genes specifically modulated in sensitized skins allow the detection of sensitizers in a reconstructed human skin model. Development of the SENS-IS assay.
|
25724174 |
2015 |
|
Disease Exacerbation
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
A gene expression signature of acquired chemoresistance to cisplatin and fluorouracil combination chemotherapy in gastric cancer patients.
|
21364753 |
2011 |
|
Hereditary Diffuse Gastric Cancer
|
0.300 |
Biomarker
|
disease |
CTD_human |
A gene expression signature of acquired chemoresistance to cisplatin and fluorouracil combination chemotherapy in gastric cancer patients.
|
21364753 |
2011 |
|
Squamous cell carcinoma
|
0.160 |
Biomarker
|
disease |
BEFREE |
Nuclear entrapment of p33ING1b by inhibition of exportin-1: A trigger of apoptosis in head and neck squamous cell cancer.
|
29729696 |
2018 |
|
Squamous cell carcinoma
|
0.160 |
Biomarker
|
disease |
HPO |
|
|
|
|
Squamous cell carcinoma
|
0.160 |
Biomarker
|
disease |
LHGDN |
Nuclear to cytoplasmic shift of p33(ING1b) protein from normal oral mucosa to oral squamous cell carcinoma in relation to clinicopathological variables.
|
17805569 |
2008 |
|
Squamous cell carcinoma
|
0.160 |
Biomarker
|
disease |
BEFREE |
Mutational analysis of the candidate tumor suppressor gene ING1 in Indian oral squamous cell carcinoma.
|
11287275 |
2001 |
|
Malignant Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
This study suggests that neither perturbation of alternative splicing, nor mutation of p33/ING1 plays a significant role in the development of haematological malignancies.
|
12008079 |
2002 |
|
Malignant Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Aberrant regulation of the translation initiation is known to contribute to tumorigenesis. eIF3 plays an important role in translation initiation. eIF3f is the p47 subunit of the eIF3 complex whose function in cancer is not clear.
|
18381585 |
2008 |
|
Malignant Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Aberrant regulation of the translation initiation is known to contribute to tumorigenesis. eIF3 plays an important role in translation initiation. eIF3f is the p47 subunit of the eIF3 complex whose function in cancer is not clear.
|
17918192 |
2008 |
|
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Inhibitor of Growth 1 (ING1) is recognized as candidate tumor suppressor.
|
18450387 |
2009 |
|
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Recently, a potential tumour suppressor gene ING1 (inhibitor of growth 1) was shown to inhibit cell growth and induce apoptosis in the presence of p53.
|
11966686 |
2002 |
|
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
These results suggest that p33(ING1) may not be a major candidate tumor suppressor gene in myeloid leukemias.
|
11835353 |
2002 |
|
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Clinical and experimental evidence suggest that the p33ING1b candidate tumor suppressor functionally cooperates with p53 in controlling biochemical and biological functions.
|
14676120 |
2003 |